Hebei Hejia Pharmaceutical Technology Group Co., Ltd. (abbreviated as “Hejia Pharmaceutical”, stock code: 838641), established in 1999, is a national high-tech enterprise and an innovative market maker listed on the NEEQ Innovation Tier (National Equities Exchange and Quotations). The group comprises three wholly-owned subsidiaries—Harbin Hejia Pharmaceutical Co., Ltd., Shijiazhuang Hejia Chemical Co., Ltd., and Shijiazhuang Zhongdan Chemical Co.,Ltd.—along with a holding subsidiary, Heilongjiang Jiahao Pharmaceutical Technology Co., Ltd., and an independent R&D institution, Hejia Research Institute.
Headquartered at No. 80 Hainan Road, Shijiazhuang Economic and Technological Development Zone, Hejia Pharma has evolved into a leading domestic manufacturer of cephalosporin antibiotic side-chain intermediates, with a vertically integrated industrial chain. Core products include AE Active Ester, Triazine Ring, and other fine chemical intermediates. The company further diversifies its portfolio through innovations like the fully biodegradable surfactant APG (Alkyl Polyglucoside).
Backed by robust technical expertise, advanced testing systems, and stringent quality controls, Hejia Pharma delivers products of exceptional quality, earning global acclaim. The company holds Municipal-Level Enterprise Technology Center certification and complies with international standards, including ISO 9001 (Quality Management), ISO 14001 (Environmental Management), and OHSAS 18001 (Occupational Health and Safety).
Equipped with current GMP certification, Hejia Pharma produces a range of cephalosporin antibiotic APIs and formulations, supported by advanced processes and facilities for traditional Chinese medicine (TCM) extraction and preparation. Its products dominate domestic and international markets, solidifying its reputation as a global leader in cephalosporin antibiotics, while expanding into high-quality TCM offerings.
Corporate Philosophy:
Quality-Driven Vision: Guided by the principle “Today’s Quality, Tomorrow’s Market”, we prioritize excellence and customer-centric innovation.
People-Centric Culture: Fostering a “home-like atmosphere”, we provide employees with a supportive work-life environment.
Sustainable Growth: Committed to eco-friendly practices, we actively build a “Green Chemical”
Vision: Partnering with global clients, Hejia Pharma strives to pioneer advancements in pharmaceuticals and green chemistry, shaping a sustainable and prosperous future.
We have obtained various certificate documents internationally
Formation of the Company;Started the production of piperazine &Triethylenediamine
Go International;Oversea network established
Growth Strategy ;developed & executed Hejia Group formed
Listed in China National Equities Exchange;India Operation (Polyco) started
APG 2nd phase done;New Polyester Polyol started
Corporate and Industrial Environments
alkyl polyglycosides
alkyl polyglucoside apg
pharmaceutical development and technology
drug development research
pharma r&d
r&d pharmaceutical
drug discovery development
Analysis experimental area 1
Analysis experimental area 2
Analysis experimental area 3
Analysis experimental area 1
Analysis experimental area 4
alkyl polyglycosides
alkyl polyglucoside apg
pharmaceutical development and technology
drug development research
pharma r&d
r&d pharmaceutical
drug discovery development
Analysis experimental area 1
Analysis experimental area 2
Analysis experimental area 3
Analysis experimental area 1
Analysis experimental area 4
Complete Control Over Products Allows Us To Ensure Our Customers Receive The Best Quality Prices And Service.
If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.